Press release
Projected Growth of the Global Filgrastim Biosimilars Market: Insights on Market Size, Key Players, Major Trends and Key Growth Drivers
Projected Growth of the Global Filgrastim Biosimilars Market
What Is The Projected Market Size Of The Global Filgrastim Biosimilars Market And Its Growth Rate?
- The Filgrastim Biosimilars Market size grew from $0.92 billion in 2024 to $0.98 billion in 2025, showcasing a CAGR of 6.9%.
- The growth in the historic period can be attributed to emerging markets growth, increase in patent expiration, and increased healthcare expenditure.
- The Filgrastim Biosimilars Market size is expected to grow to $1.21 billion in 2029 at a CAGR of 5.4%.
- The growth in the forecast period can be attributed to aging population and increase in healthcare access.
What Is Driving The Growth In The Filgrastim Biosimilars Market?
The increasing prevalence of neutropenia, a condition characterized by insufficient neutrophils - an important white blood cell type that fights infections is expected to fuel the growth of the Filgrastim Biosimilar Market. Filgrastim biosimilars stimulate neutrophil production in the bone marrow, increasing neutrophil count and bolstering the body's ability to fight off infections. According to data from the National Center for Biotechnology Information (August 2022), the prevalence of neutropenia was 0.38% among Mexican-Americans, 0.79% among whites, and 4.5% among black participants. This increase in prevalence is a key driver of filgrastim biosimilar market growth.
Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4016&type=smp
Who Are the Key Players Driving Filgrastim Biosimilars Market Growth?
•Teva Pharmaceutical Industries Ltd
•Novartis International AG
•Biocon Limited
•Intas Biopharmaceuticals
•Dr. Reddy's Laboratories
•Pfizer
•Cadila Healthcare Ltd
•Reliance Life Science Pvt. Ltd
•Gennova Biopharmaceuticals (Emcure)
•Sandoz Pty Ltd
•Mylan
•Lupin Limited
•Coherus Biosciences Inc.
•North China Pharmaceutical Corporation
•Tonghua Dongbaoare
•Beijing SL Pharmaceutical
•Fuji Pharma
•Adello Biologics
•Apobiologix (Apotex)
•Hospira
•Tanvex BioPharma
•Eurofarma Laboratórios
What Are The Key Trends In The Filgrastim Biosimilars Market?
- Investing extensively in R&D activities for the development of effective and innovative biosimilars
- Production of biosimilars for neutropenia treatment to improve revenues
- Increasing focus on M&A growth strategies
What Are The Segments Of The Global Filgrastim Biosimilars Market?
1) By Type Of Manufacturing: In-House Manufacturing, Contract Manufacturing organization
2) By Application: Oncology, Chronic And Autoimmune Diseases, Blood Disorders, Growth Hormone Deficiency, Other Applications
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Which Region Leads The Filgrastim Biosimilars Market?
North America led the Filgrastim Biosimilars market in 2024, while the Middle East is anticipated to be the fastest-growing region in the market during the forecast period. The report covers regions including Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Pre-book the Report for Swift Delivery:
https://www.thebusinessresearchcompany.com/report/filgrastim-biosimilar-global-market-report
What Is Covered In The Filgrastim Biosimilars Market Global Market Report?
- Market Size Analysis: Analyze the Filgrastim Biosimilars Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Filgrastim Biosimilars Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Filgrastim Biosimilars Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Filgrastim Biosimilars Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Request Customization for This Report:
https://www.thebusinessresearchcompany.com/customise?id=4016&type=smp
Learn More About The Business Research Company
Learn More About the Business Research Company. With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
•LinkedIn: https://in.linkedin.com/company/the-business-research-company
•Twitter: https://twitter.com/tbrc_info
•YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
Learn More About the Business Research Company. With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Projected Growth of the Global Filgrastim Biosimilars Market: Insights on Market Size, Key Players, Major Trends and Key Growth Drivers here
News-ID: 3835999 • Views: …
More Releases from The Business research company
Comprehensive Construction Project Insurance Market Forecast 2025-2034: Growth T …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Construction Project Insurance Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In the last few years, the construction project insurance market has seen robust growth. The market size is projected to increase from $7.91 billion in 2024 to $8.38 billion in 2025, registering a compound…
Charity Fundraising Platform Market Expansion Continues, with Forecast Valuation …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Charity Fundraising Platform Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size of the charity fundraising platform has experienced a significant boost in recent times. It is projected to ascend from $6.76 billion in 2024 to $7.70 billion in 2025, representing an impressive…
Cured In Place Pipe (CIPP) Liner Market Expected to Achieve 8.2% CAGR by 2029: G …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Cured In Place Pipe (CIPP) Liner Market Size By 2025?
The market size for the cured in place pipe (CIPP) liner has seen significant growth lately. The projected growth is from $2.53 billion in 2024 to $2.75 billion in 2025, with a compound annual growth…
Comprehensive Cementitious Concrete Repair Mortar Market Forecast 2025-2034: Gro …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Cementitious Concrete Repair Mortar Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
There has been considerable growth in the market for cementitious concrete repair mortar in recent times. The market's worth is predicted to increase from $2.00 billion in 2024 to $2.15 billion in 2025,…
More Releases for Filgrastim
Filgrastim Injection Market Is Booming So Rapidly with Amgen, Sandoz, Teva Pharm …
HTF Market Insights just released the Global Filgrastim Injection Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Major companies Filgrastim Injection Market are:
Amgen, Sandoz, Teva Pharmaceutical,…
2024 Filgrastim Biosimilars Market: Size, Growth, Share, Trends, Forecast To 203 …
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Filgrastim Biosimilars Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $1.66 billion In 2028 At…
Filgrastim Biosimilars Global Market Analysis, Trends, Growth, Research And Fore …
The filgrastim biosimilars market size has grown strongly in recent years. It will grow from $1.02 billion in 2023 to $1.1 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to emerging markets growth, increase in patent expiration, government initiatives, increased healthcare expenditure, low cost of biosimilars, strong pipeline of drugs and increase in biopharmaceutical r&d…
Filgrastim Biosimilars Market Size, Share And Trends Analysis Report 2024-2033
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033
The Business Research Company presents an extensive market research report on the Filgrastim Biosimilars Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments.
Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities,…
Filgrastim Market Is Likely to Experience a Tremendous Growth by 2029
Filgrastim Market was valued at USD 992.8 million in 2022 and is expected to grow at a CAGR of 8% between 2023 and 2029. Filgrastim Market research involves carrying out thorough research on market to help newly emerging players in making calculated decision regarding which business ideas to follow. It is carried out to assess the viability of novel product or service. There are a few important goals can be…
Filgrastim Market Report, History and Forecast 2023-2031
The report extensively examines the global Filgrastim market while focusing on the leading companies and their business strategies, geographical growth, market segmentation, competitive environment, production, price, and cost structures. Each section of the research report has been carefully designed to examine important facets of the global market for Filgrastim. For instance, the market dynamics section delves deeply into the trends, opportunities, and drivers influencing the global market for Filgrastim. We…
